pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of CYP3A4 inducers may reduce sufentanil levels and efficacy, possibly precipitating withdrawal syndrome in individuals who may have created Act